[A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea]
- PMID: 20236813
- DOI: 10.1016/j.arcped.2010.02.004
[A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea]
Abstract
Aim of the study: In a double-blind, randomized, controlled, multicentric study, the study compared the efficacy of a specific adapted formula (lactose-free, high-mineral, low-osmolarity formula, containing rice and pectin fortified with Saccharomyces boulardii) in the management of infants with acute diarrhea with a standard formula used to feed healthy infants from birth.
Methodology: Seventy infants with an average age of 163 days+/-11.7 suffering from acute diarrhea with an average of 6.6+/-0.4 stools per day received, after randomization, either a standard (control) formula (n=36) or an adapted lactose-free formula fortified with S. boulardii (26mg/100ml; n=34). The duration of the diarrhea was defined as the time needed until the occurrence of the first normal stool after the last liquid stool.
Results: At inclusion, the age, weight, and number of stools per day were the same in the two groups. There were 15 infants with rotavirus in the treated group and 13 in the control group. The duration of the diarrhea from time of inclusion was significantly reduced in the treated group (35.4+/-3.7h) versus the control group (67.1+/-5h; p<0.001), In both groups, with or without rotavirus, the duration of diarrhea did not depend on the presence or absence of rotavirus but only on the treatment. The average daily weight gain was significantly higher in the treated group compared with the control group (74.2+/-26.4g versus 23.7+/-6.7g; p<0.05). The oral rehydration solution consumption was, however, higher in the control group than in the treated group; the consumption of formula was higher in the treated group, but these differences were not significant. The number of stools as of Day 4 remained significantly higher in the control group than in the treated group. After 6.5 days, almost no S. boulardii was found in the stools.
Conclusion: In moderately dehydrated infants (<10 %), the use of a specially designed formula, containing S. boulardii (Novalac AD+/Diarinova+), significantly shortens the duration of diarrhea and allows quicker weight regain than a standard formula.
Copyright 2010 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Randomized, double-blind clinical trial of a lactose-free and a lactose-containing formula in dietary management of acute childhood diarrhea.J Med Assoc Thai. 2004 Jun;87(6):641-9. J Med Assoc Thai. 2004. PMID: 15279342 Clinical Trial.
-
The effect of early nutritional supplementation with a mixture of probiotic, prebiotic, fiber and micronutrients in infants with acute diarrhea in Indonesia.Asia Pac J Clin Nutr. 2007;16(3):435-42. Asia Pac J Clin Nutr. 2007. PMID: 17704024 Clinical Trial.
-
Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study.Am J Trop Med Hyg. 2008 Feb;78(2):214-6. Am J Trop Med Hyg. 2008. PMID: 18256417 Clinical Trial.
-
[Prevention and treatment of acute diarrhea in infants].Arch Pediatr. 2007 Nov;14(11):1375-8. doi: 10.1016/j.arcped.2007.06.009. Epub 2007 Jul 16. Arch Pediatr. 2007. PMID: 17629685 Review. French.
-
Milk protein-based infant formula containing rice starch and low lactose reduces common regurgitation in healthy term infants: a randomized, blinded, and prospective trial.J Am Coll Nutr. 2014;33(2):136-46. doi: 10.1080/07315724.2013.828578. J Am Coll Nutr. 2014. PMID: 24724771 Review.
Cited by
-
Probiotics for treating acute infectious diarrhoea.Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048. doi: 10.1002/14651858.CD003048.pub4. Cochrane Database Syst Rev. 2020. PMID: 33295643 Free PMC article.
-
Retrospective analysis of EMR database to assess the effectiveness of Saccharomyces boulardii CNCM I-745 in children with acute diarrhoea during routine clinical practice.New Microbes New Infect. 2020 Sep 20;38:100766. doi: 10.1016/j.nmni.2020.100766. eCollection 2020 Nov. New Microbes New Infect. 2020. PMID: 33093961 Free PMC article.
-
The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature.Microorganisms. 2022 Dec 2;10(12):2392. doi: 10.3390/microorganisms10122392. Microorganisms. 2022. PMID: 36557645 Free PMC article. Review.
-
Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial.Indian J Pediatr. 2012 Apr;79(4):478-82. doi: 10.1007/s12098-011-0573-z. Epub 2011 Oct 14. Indian J Pediatr. 2012. PMID: 21997865 Clinical Trial.
-
Probiotics for treating acute infectious diarrhoea.Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003048. doi: 10.1002/14651858.CD003048.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2020 Dec 8;12:CD003048. doi: 10.1002/14651858.CD003048.pub4. PMID: 21069673 Free PMC article. Updated.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials